Lorenzen S, Gotze TO, Thuss-Patience P, Biebl M, et al. Perioperative Atezolizumab Plus Fluorouracil, Leucovorin, Oxaliplatin, and Docetaxel for Resectable Esophagogastric Cancer: Interim Results From the Randomized, Multicenter, Phase II/III DANTE/IKF-s633 Trial. J Clin Oncol 2023 Nov 14:JCO2300975. doi: 10.1200/JCO.23.00975.
PMID: 37963317